Search Results

You are looking at 61 - 70 of 1,071 items for :

  • prostate cancer x
  • Refine by access: All content x
Clear All
Rosalinda M Savoy Departments of Urology, Biochemistry and Molecular Medicine, VA Northern California Health Care System, University of California Davis, Sacramento, California, USA
Departments of Urology, Biochemistry and Molecular Medicine, VA Northern California Health Care System, University of California Davis, Sacramento, California, USA

Search for other papers by Rosalinda M Savoy in
Google Scholar
PubMed
Close
and
Paramita M Ghosh Departments of Urology, Biochemistry and Molecular Medicine, VA Northern California Health Care System, University of California Davis, Sacramento, California, USA
Departments of Urology, Biochemistry and Molecular Medicine, VA Northern California Health Care System, University of California Davis, Sacramento, California, USA
Departments of Urology, Biochemistry and Molecular Medicine, VA Northern California Health Care System, University of California Davis, Sacramento, California, USA

Search for other papers by Paramita M Ghosh in
Google Scholar
PubMed
Close

Prostatitis, or inflammation of the prostate, may occur in men as young as 40, or even younger, while prostate cancer and benign prostatic hyperplasia (BPH, or enlargement of the prostate) are most often diagnosed in men above 50. While prostatitis

Free access
S Leskelä
Search for other papers by S Leskelä in
Google Scholar
PubMed
Close
,
E Honrado
Search for other papers by E Honrado in
Google Scholar
PubMed
Close
,
C Montero-Conde
Search for other papers by C Montero-Conde in
Google Scholar
PubMed
Close
,
I Landa
Search for other papers by I Landa in
Google Scholar
PubMed
Close
,
A Cascón
Search for other papers by A Cascón in
Google Scholar
PubMed
Close
,
R Letón
Search for other papers by R Letón in
Google Scholar
PubMed
Close
,
P Talavera
Search for other papers by P Talavera in
Google Scholar
PubMed
Close
,
J M Cózar
Search for other papers by J M Cózar in
Google Scholar
PubMed
Close
,
A Concha
Search for other papers by A Concha in
Google Scholar
PubMed
Close
,
M Robledo
Search for other papers by M Robledo in
Google Scholar
PubMed
Close
, and
C Rodríguez-Antona
Search for other papers by C Rodríguez-Antona in
Google Scholar
PubMed
Close

Introduction Prostate cancer is the second leading cause of cancer death in men, and both genetic and environmental factors have been shown to be important for the development of this disease ( Novelli et al. 2004 ). More than 95

Free access
Ruth Foley Department of Haematology and Oncology, Institute of Molecular Medicine, St James’ Hospital, James’ St, Dublin 8, Ireland

Search for other papers by Ruth Foley in
Google Scholar
PubMed
Close
,
Donal Hollywood Department of Haematology and Oncology, Institute of Molecular Medicine, St James’ Hospital, James’ St, Dublin 8, Ireland

Search for other papers by Donal Hollywood in
Google Scholar
PubMed
Close
, and
Mark Lawler Department of Haematology and Oncology, Institute of Molecular Medicine, St James’ Hospital, James’ St, Dublin 8, Ireland

Search for other papers by Mark Lawler in
Google Scholar
PubMed
Close

Introduction Prostate cancer represents one in ten cases of cancer in men, and 200 000 deaths per year, worldwide ( Parkin et al. 2001 ). Because the disease is more common among older men, its incidence is expected to

Free access
P Singh Chemical Therapeutics Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 1650 Orleans St. – CRB 162B, Baltimore, Maryland 21231, USA

Search for other papers by P Singh in
Google Scholar
PubMed
Close
,
A Uzgare Chemical Therapeutics Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 1650 Orleans St. – CRB 162B, Baltimore, Maryland 21231, USA

Search for other papers by A Uzgare in
Google Scholar
PubMed
Close
,
I Litvinov Chemical Therapeutics Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 1650 Orleans St. – CRB 162B, Baltimore, Maryland 21231, USA

Search for other papers by I Litvinov in
Google Scholar
PubMed
Close
,
S R Denmeade Chemical Therapeutics Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 1650 Orleans St. – CRB 162B, Baltimore, Maryland 21231, USA

Search for other papers by S R Denmeade in
Google Scholar
PubMed
Close
, and
J T Isaacs Chemical Therapeutics Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 1650 Orleans St. – CRB 162B, Baltimore, Maryland 21231, USA

Search for other papers by J T Isaacs in
Google Scholar
PubMed
Close

Introduction Androgens are the major growth factors for the normal prostate, and its cognate receptor is fundamental for androgen signaling within the gland. Prostate cancers retain androgen receptor (AR) signaling pathways and thus

Free access
Subing Cao College of Life Sciences, Jilin University, Changchun, Jilin, China
Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana, USA

Search for other papers by Subing Cao in
Google Scholar
PubMed
Close
,
Yang Zhan College of Life Sciences, Jilin University, Changchun, Jilin, China
Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana, USA

Search for other papers by Yang Zhan in
Google Scholar
PubMed
Close
, and
Yan Dong College of Life Sciences, Jilin University, Changchun, Jilin, China
Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana, USA

Search for other papers by Yan Dong in
Google Scholar
PubMed
Close

Introduction The androgen receptor (AR) signaling pathway remains active in castration-resistant prostate cancer (CRPC) (reviewed in Knudsen & Scher 2009 , Egan et al . 2014 , Kahn et al . 2014 ). Mechanisms leading to AR reactivation

Free access
Nima Sharifi
Search for other papers by Nima Sharifi in
Google Scholar
PubMed
Close
,
James L Gulley Division of Hematology and Oncology, Medical Oncology Branch, Laboratory of Tumor Immunology and Biology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8852, USA
Division of Hematology and Oncology, Medical Oncology Branch, Laboratory of Tumor Immunology and Biology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8852, USA

Search for other papers by James L Gulley in
Google Scholar
PubMed
Close
, and
William L Dahut Division of Hematology and Oncology, Medical Oncology Branch, Laboratory of Tumor Immunology and Biology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8852, USA

Search for other papers by William L Dahut in
Google Scholar
PubMed
Close

Introduction In 2009 alone, there were an estimated 192 280 new cases of prostate cancer and 27 360 estimated deaths due to prostate cancer in the United States ( Jemal et al . 2009 ). Depletion of gonadal testosterone through androgen deprivation

Free access
Amina Zoubeidi Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada

Search for other papers by Amina Zoubeidi in
Google Scholar
PubMed
Close
and
Paramita M Ghosh Department of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, California, USA
Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, California, USA
Department of Veterans Affairs, Northern California Health Care System, Mather, California, USA

Search for other papers by Paramita M Ghosh in
Google Scholar
PubMed
Close

Introduction Localized prostate cancer can be treated with surgery; however, metastasized prostate cancer is usually treated with hormonal ablation. Improved diagnostic tools and earlier diagnosis has helped increase the 10-year survival of

Free access
B Cioni Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, the Netherlands

Search for other papers by B Cioni in
Google Scholar
PubMed
Close
,
W Zwart Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands

Search for other papers by W Zwart in
Google Scholar
PubMed
Close
, and
A M Bergman Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands

Search for other papers by A M Bergman in
Google Scholar
PubMed
Close

Prostate cancer Prostate cancer (PCa) is the second-most frequently diagnosed tumor type in men worldwide and the most-common male malignancy in developed countries ( Torre et al . 2015 ). Annually, there are an estimated 1.1 million new

Free access
Chun-Te Wu
Search for other papers by Chun-Te Wu in
Google Scholar
PubMed
Close
,
Wen-Cheng Chen
Search for other papers by Wen-Cheng Chen in
Google Scholar
PubMed
Close
,
Shuen-Kuei Liao
Search for other papers by Shuen-Kuei Liao in
Google Scholar
PubMed
Close
,
Cheng-Lung Hsu
Search for other papers by Cheng-Lung Hsu in
Google Scholar
PubMed
Close
,
Kuan-Der Lee
Search for other papers by Kuan-Der Lee in
Google Scholar
PubMed
Close
, and
Miao-Fen Chen
Search for other papers by Miao-Fen Chen in
Google Scholar
PubMed
Close

Introduction Because the initiation and progression of prostate cancer depend on androgen receptors (AR) to mediate the androgen effect in most cases ( Chang et al. 1995 ), standard hormone therapy aims to inactivate AR

Free access
Peder Rustøen Braadland Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Search for other papers by Peder Rustøen Braadland in
Google Scholar
PubMed
Close
and
Alfonso Urbanucci Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway
Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, Oslo, Norway

Search for other papers by Alfonso Urbanucci in
Google Scholar
PubMed
Close

Introduction Prostate cancer (PC) is the most common cancer in North American and European men. Despite the recent decrease in mortality rate in Nordic countries ( Kvale et al. 2017 ), PC represents the second leading cause of cancer

Free access